Friday, 5 November 2021

I'd stand in line for Pfizer's Paxlovid pill.

Pfizer is coming up with a pill that works somewhat like the HIV treatment protocol and you don't take it unless you get sick.  It's a protease inhibitor that suppresses an enzyme that gets hijacked by the virus for its own ends.  It doesn't inject genetic material.  I refused to be a vaxx guinea pig but I'd stand in line for this pill if the approvals look solid.  Maybe someday I can dine out in beautiful BC's restaurants again and go on the inland waters cruise.    (See Caveats below)

The pill is branded as Paxlovid, to be taken within 5 days of symptoms of Covid-19 showing, combined with a low dose of Ritonavir.  
From Wikipedia:  Ritonavir, which is also a protease inhibitor used in some HIV treatment, sounds like a normal addition in such a scenario.

"Ritonavir (RTV), sold under the brand name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS. This combination treatment is known as highly active antiretroviral therapy (HAART). Often a low dose is used with other protease inhibitors".

Continuing tests include vaccinated people with breakthrough infections. 
A fairly complete Canadian writeup is here at CTV.  

Caveat:  Everything you read for the next few weeks is a re-hash of a Pfizer press release.
Caveat:  The promising results refer to hospitalizations and to deaths.  The total of deaths in the control group was 10, a small number to generalize from, even though there were no deaths in the treated group.  The numbers who were spared hospitalization are more significant.  Pfizer collapsed the control group because it seemed unethical not to offer the same treatment to them.  Sadly, the same was done with the gene vaccination trials whose disturbing consequences are still being discovered.

No comments:

Post a Comment